4.18
Cryo Cell International Inc stock is traded at $4.18, with a volume of 4,139.
It is up +0.00% in the last 24 hours and up +19.43% over the past month.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
See More
Previous Close:
$4.18
Open:
$4.26
24h Volume:
4,139
Relative Volume:
0.21
Market Cap:
$32.57M
Revenue:
$31.28M
Net Income/Loss:
$-2.67M
P/E Ratio:
-12.61
EPS:
-0.3315
Net Cash Flow:
$4.94M
1W Performance:
+5.56%
1M Performance:
+19.43%
6M Performance:
+24.59%
1Y Performance:
-8.13%
Cryo Cell International Inc Stock (CCEL) Company Profile
Name
Cryo Cell International Inc
Sector
Industry
Phone
813 749 2100
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar
Compare CCEL vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 5.10 | 0 | 0 | 0 | 0 | 0.00 | |
|
MOBBW
Mobilicom Limited Warrants
|
2.29 | 2.99B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.74 | 401.38M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.98 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.75 | 314.59M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
48.06 | 0 | 0 | 0 | 0 | 0.00 |
Cryo Cell International Inc Stock (CCEL) Latest News
Cryo-Cell (CCEL) Earnings Snapshot: The EPS Result Is Above Expectation for the Current Session; Post-Earnings: The Stock Ends Up 3.56% in Latest TradingFree Cash Flow Trends - Vinanet
JEXYY Stock Price and Chart — OTC:JEXYY - TradingView
CCEL Q2 2026 Earnings: EPS of $0.07 Exceeds Expectations, Stock Edges HigherSurprise Factor Analysis - Vinanet
Cell Processing Technologies Market Demonstrates Long-Term Growth Potential At 13.5% CAGR - openPR.com
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
CCEL Q2 2026 Earnings: EPS Exceeds Estimates as Shares Rally 14.25%Earnings Season Outlook - Vinanet
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsOverbought Signal Alerts - Vinanet
SARO Stock Price and Chart — NYSE:SARO - TradingView
Cryo-Cell International (CCEL) moves 600,191 shares to new 2026 trust - Stock Titan
Cryo-Cell International Inc (CCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cryo-Cell International (CCEL) Holds Steady at $3.59 as Shares Approach Key ResistancePSAR Stop - dars.gov.et
Cryo-Cell International (CCEL) Gains 2.25% as Stock Holds Above Key SupportRetail Sentiment - Vinanet
Cryo-Cell International (CCEL) Advances 2.3%: Stem Cell Banking Stock Tests Key ResistanceVolume Profile - dars.gov.et
Cryo-Cell International, Inc. Revenue Breakdown – AMEX:CCEL - TradingView
Cryo-Cell International Inc (CCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CCEL Q2 2026 Earnings: Positive Earnings Surprise as EPS Turns ProfitableDownward Estimate Revision - dars.gov.et
Cryo-Cell International Inc (CCEL) Balance Sheet - tradingkey.com
Cryo-Cell International Inc (CCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
CCEL|Cryo-Cell International Inc|Price:3.460|Chg%:+0.040 - tradingkey.com
CCEL|Cryo-Cell International Inc|Price:3.460| - TradingKey
Cryo-Cell International Inc (CCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cryo-Cell International, Inc. Revenue Breakdown – FWB:ZCY - TradingView
Cryo-Cell International Inc (CCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cryo-Cell International (CCEL) Slips Slightly, Holds Above Key Support at $3.29Volume Gap - Vinanet
Cryo-Cell International Inc (CCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cryo-Cell International Inc (CCEL) Income Statement - TradingKey
CCEL|Cryo-Cell International Inc|Price:3.600|Chg%:+0.020 - TradingKey
Cryo-Cell International (CCEL) Slips 1.14% as Stock Consolidates Near Key SupportSector ETF Flow - Vinanet
CCEL Q2 2026 Earnings: Positive EPS Surprise Amid Quiet Revenue DisclosureOperating Margin Analysis - Vinanet
Stem Cell Banking Market Size, Growth & Analysis, 2034 - Market Data Forecast
CCEL Q2 2026 Earnings: Positive EPS Surprise Amidst Operational ProgressEarnings Sentiment Score - Vinanet
Cryo-Cell International (CCEL) Hovers Near Support as Trading Volume Remains SubduedEarnings Miss Risk - Vinanet
CCEL Q2 2026 Earnings: EPS Surprises to Positive Territory Despite Stock DeclineDividend Growth Analysis - Vinanet
Cryo-Cell net income rises 56% to $555,000 in Q2 - scanx.trade
Cryo-Cell International Q2 Revenue USD 7.8 Million - TradingView
CCEL Reports Slight Decrease in Q2 Revenue - GuruFocus
CRYO CELL INTERNATIONAL INC Q2 2026: Revenue $7.78M (Q2), $15.46M (6 months) — 10-Q Summary - TradingView
CCEL: Revenue and net income declined, with expansion paused due to Duke arbitration and NYSE compliance risks - TradingView
[10-Q] CRYO CELL INTERNATIONAL INC Quarterly Earnings Report - Stock Titan
Tranche Update on Cryo-Cell International, Inc.'s Equity Buyback Plan announced on December 12, 2011. - marketscreener.com
Press Release: Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results - Moomoo
MSN Money - MSN
CCEL Q1 2026 Earnings: Surprise Profit Beat Amid Revenue UncertaintyEPS Estimate Trend - dars.gov.et
Cryo-Cell International | SCHEDULE 13D/A: Others - Moomoo
Form 13D/A CRYO CELL INTERNATIONAL INC For: 7 July By Investing.com - Investing.com Canada
Camac Fund holds 6.8% Cryo-Cell (CCEL) stake and may engage board - Stock Titan
Price to sales forward of Cryo-Cell International, Inc. – AMEX:CCEL - TradingView
CCEL Q1 2026 Earnings: Surprise Profitability as EPS Beats EstimatesRevenue Report - dars.gov.et
Cryo-Cell International (CCEL) Gains 1.83% as Momentum Builds Near SupportIchimoku Cloud - dars.gov.et
CCEL Q1 2026 Earnings: Positive EPS Surprise Marks Turnaround from Expected LossDividend Growth Analysis - dars.gov.et
Stem Cell Banking Market Size, Share, Industry Trends and Forecast 2026-2034 - openPR.com
Cryo Cell International Inc Stock (CCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cryo Cell International Inc Stock (CCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 16 '25 |
Buy |
4.46 |
6,449 |
28,763 |
818,369 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 17 '25 |
Buy |
4.43 |
5,564 |
24,649 |
823,933 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 18 '25 |
Buy |
4.46 |
3,411 |
15,213 |
827,344 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 18 '25 |
Buy |
4.49 |
1,751 |
7,862 |
161,833 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 10 '25 |
Buy |
4.44 |
25,139 |
111,692 |
268,878 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 10 '25 |
Buy |
4.42 |
7,178 |
31,727 |
811,920 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 09 '25 |
Buy |
4.49 |
5,312 |
23,849 |
257,843 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 08 '25 |
Buy |
4.31 |
5,271 |
22,718 |
253,028 |
| PORTNOY DAVID | Chairman, Co-CEO |
Aug 25 '25 |
Buy |
4.61 |
14,000 |
64,560 |
241,539 |
| PORTNOY DAVID | Chairman, Co-CEO |
Aug 27 '25 |
Buy |
4.43 |
14,078 |
62,349 |
247,757 |
Cap:
|
Volume (24h):